Singapore General Hospital will NEVER ask you to transfer money over a call. If in doubt, call the 24/7 ScamShield helpline at 1799, or visit the ScamShield website at www.scamshield.gov.sg.
We’d love to hear from you! Rate the SGH website and share your feedback so we can enhance your online experience and serve you better. Click here to rate us
Pioneering advancements in precision medicine, SGH’s Precision Medicine team develops innovative AI solutions that transform traditional diagnostic approaches. Through our groundbreaking (Haematoxylin and Eosin) H&E 2.0 technology, we're enhancing clinical trial processes and revolutionising biomarker detection, making healthcare more precise and accessible.
Our flagship H&E 2.0 technology delivers virtual immunohistochemistry (IHC) staining at the single-cell level, enabling detailed visualisation of the tumour microenvironment. Through AI-powered biomarker detection from routine H&E images, we provide cost-effective solutions for clinical trial patient triaging. The technology has proven successful across multiple applications, including (programmed cell death ligand 1) PD-L1 detection, immune tumour analysis, and antibody-drug conjugate targeting.
Addresses >90% clinical trial failure rates
Reduces potential annual losses exceeding USD 9 billion
Optimises resource allocation in patient screening
Streamlines clinical trial recruitment processes
Our innovation pipeline includes:
Our multi-disciplinary team brings together pathologists, immunologists, histotechnicians, informaticians, and AI scientists under one roof, removing barriers between expertise domains. With over 100 published papers and leadership in global initiatives such as the Society for Immunotherapy of Cancer and Medical Image Computing and Computer Assisted Intervention, we offer unique technical expertise and market seniority in AI-powered precision medicine solutions.
Innovation waits for no one. Get in touch with us.
Stay Healthy With
© 2025 SingHealth Group. All Rights Reserved.